Oct. 20, 2011
Contact: Liz Dowling, (415) 3888-2794
Dowling & Dennis Public Relations
E-mail:Liz@DowlingDennis.net
Dr. Kambiz Dowlat, Developer of Novilase Laser Therapy for Breast Tumors, Is One of the Inaugural ‘Pink Tie Guys’ CHICAGO – Kambiz Dowlat M.D., founder of Novian Health, has been honored by the Chicagoland Area Affiliate of Susan G. Komen for the Cure® in the inaugural class of Pink Tie Guys.
Dr. Dowlat, developer of Novilase® image-guided laser therapy for breast tumors, is one of what the organization called “an exclusive group of KoMEN making a difference in the fight against breast cancer.”
The Pink Tie Guys, who were nominated by the community and selected by the Komen Chicagoland Board of Directors, were honored Oct.13 at Tribune Media Group’s Pink Tie Gala attended by Illinois Gov. Pat Quinn. In addition to Dr.Dowlat, former Chicago Mayor Richard M. Daley was among the honorees.
“This prestigious award demonstrates yet again the value of Dr. Dowlat’s research. It’s a gratifying recognition of his longstanding dedication to improving women’s breast health,” said Henry “Chip” Appelbaum,President and CEO of NovianHealth.
Dr. Dowlat, a Professor of Surgery atRush University Medical Center, is a pioneer of minimally invasive breast cancer procedures. He performed the groundbreaking research that formed the basis for the multi-center breast cancer trial that Novian is launching, having recently received approval of an investigational device exemption(IDE) from the FDA.
Novian developed the Novilase ILT System for the ablation of small (up to 20mm) malignant breast tumors. The company has previously received FDA 510(k)clearance for the treatment of breast fibroadenomas and currently offers Novilase at breast centers around the country that are participating in its ABLATE registry.
The Chicagoland Affiliate of Susan G. Komen for the Cure® was established in 1997 and held the first Susan G. Komen Chicago Race for the Cure®. The affiliate has awarded nearly $11 million towards the fight against breast cancer by funding grassroots breast health education and breast cancer screening and treatment projects, as well as national research.
About Novilase
Novilase is a laser-based device for destroying tumors. This minimally invasive alternative to conventional surgery provides a safe tumor treatment alternative while preserving the patient’s options for additional procedures or adjunctive therapies. This image-guided outpatient procedure does not require general anesthetic or a hospital stay. Multiple tumors can be treated during a single visit. Therapy outcomes may be assessed using a variety of currently available imaging technologies and other methods. Therapy consists of physician placement of two small gauge needles into the tumor site after localanesthetic, followed by initiation of the computer-controlled Novilase system. Treatment times vary from 15-30 minutes
About Novian Health
Novian Health Inc., located in Chicago, is a privately held medical device company with proprietary technology for the treatment of tumors using Interstitial Laser Therapy (ILT). Developed as an alternative to surgery, the company’s technology uses parametrically controlled heating for the ablation of tumors.Image-guided treatment of breast tumors is the first application of the technology, and Novilase also has the potential to treat tumors elsewhere in the body.
For more information, call (312) 266-7200 or access www.novianhealth.com and www.novilase.com
